MTACU has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MTACU has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
MedTech Acquisition's change in inventory for the quarter that ended in Jun. 2023 was $0.00 Mil. It means MedTech Acquisition's inventory stayed the same from Mar. 2023 to Jun. 2023 .
MedTech Acquisition's change in inventory for the fiscal year that ended in Dec. 2022 was $0.00 Mil. It means MedTech Acquisition's inventory stayed the same from Dec. 2021 to Dec. 2022 .
MedTech Acquisition's Total Inventories for the quarter that ended in Jun. 2023 was $0.00 Mil.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
The historical data trend for MedTech Acquisition's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedTech Acquisition Annual Data | |||||||
Trend | Dec20 | Dec21 | Dec22 | ||||
Change In Inventory | - | - | - |
MedTech Acquisition Quarterly Data | ||||||||||||
Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Change In Inventory | Get a 7-Day Free Trial | - | - | - | - | - |
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedTech Acquisition (NAS:MTACU) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
MedTech Acquisition's Days Inventory for the quarter that ended in is calculated as:
Days Inventory | = | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period |
= | 0 | / | 0 | * | 365 / 4 | |
= | N/A |
2. Inventory Turnover measures how fast the company turns over its inventory within a year.
MedTech Acquisition's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 0 | / | 0 | |
= | N/A |
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
MedTech Acquisition's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0 | / | 0 | |
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of MedTech Acquisition's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Magnetar Financial Llc | 10 percent owner | 1603 ORRINGTON AVE., 13TH FLOOR, EVANSTON IL 60201 |
Magnetar Capital Partners Lp | 10 percent owner | 1603 ORRINGTON AVE., 13TH FLOOR, EVANSTON IL 60201 |
Supernova Management Llc | 10 percent owner | 1603 ORRINGTON AVENUE, 13TH FLOOR, EVANSTON IL 60201 |
David J. Snyderman | 10 percent owner | C/O MAGNETAR FINANCIAL LLC, 1603 ORRINGTON AVENUE, 13TH FLOOR, EVANSTON IL 60201 |
David L Treadwell | director | 222 S 15TH STREET, SUITE 600 N, OMAHA NE 68102 |
Manuel Aguero | director | 600 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10022 |
Thierry B. Thaure | director | 3957 POINT EDEN WAY, HAYWARD CA 94545 |
David J Matlin | director, 10 percent owner, officer: Chief Financial Officer | |
Karim Karti | director | C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 500, SAN FRANCISCO CA 94103 |
Christopher C Dewey | director, 10 percent owner, officer: Chief Executive Officer | 120 BROADWAY, 27TH FLOOR, NEW YORK NY 10271 |
Robert H. Weiss | officer: Chief Admin Officer and Sec. | 585 WEED STREET, NEW CANAAN CT 06840 |
Maurice R Ferre | director | C/O MAKO SURGICAL CORP., 2555 DAVIE ROAD, FORT LAUDERDALE FL 33317 |
Ivan Delevic | director | C/O MAKO SURGICAL CORP., 2555 DAVIE ROAD, SUITE 110, FORT LAUDERDALE FL 33317 |
Medtech Acquisition Sponsor Llc | 10 percent owner | 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105 |
Martin William Roche | director | 600 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10022 |
From GuruFocus
By PRNewswire PRNewswire • 08-19-2021
By GlobeNewswire GlobeNewswire • 12-22-2020
By Business Wire Business Wire • 06-12-2023
By GuruFocusNews GuruFocusNews • 03-10-2022
By Business Wire Business Wire • 02-21-2023
By Marketwired Marketwired • 12-23-2020
By GuruFocus Research • 07-28-2023
By Marketwired Marketwired • 02-06-2021
By Marketwired Marketwired • 06-02-2021
By GuruFocus Research • 08-15-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.